DUBLIN, Ireland, Nov. 02, 2017 -- Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conferences in November:
Stifel 2017 Healthcare Conference
- Date: Tuesday, Nov. 14, 2017
- Presentation Time: 9:30 a.m. EST
- Location: New York, NY
Jefferies 2017 London Healthcare Conference
- Date: Thursday, Nov. 16, 2017
- Presentation Time: 2:40 p.m. GMT
- Location: London, United Kingdom
Piper Jaffray 29th Annual Healthcare Conference
- Date: Tuesday, Nov. 28, 2017
- Presentation Time: 11:30 a.m. EST
- Location: New York, NY
Bank of America/Merrill Lynch 2017 Leveraged Finance Conference
- Date: Wednesday, Nov. 29, 2017
- Presentation Time: 1:30 p.m. EST
- Location: Boca Raton, FL
Horizon Pharma’s presentations at these conferences will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. A replay of the webcasts will be available for the events.
About Horizon Pharma plc
Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units. For more information, please visit www.horizonpharma.com. Follow @HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Investors:
Tina Ventura
Senior Vice President,
Investor Relations
[email protected]
Ruth Venning
Executive Director,
Investor Relations
[email protected]
U.S. Media:
Geoff Curtis
Senior Vice President,
Corporate Affairs & Chief Communications Officer
[email protected]
Ireland Media:
Ray Gordon
Gordon MRM
[email protected]


Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



